WAT · News · 20260805N

Acquisition / Partnership / Divestiture

WATERS CORP /DE/ · 2026-08-05 · Importance 71 · Surprise 60

Waters completed the combination with Becton Dickinson’s former Biosciences and Diagnostic Solutions businesses during 2026. The transaction added significant revenue and produced stronger-than-expected growth in the acquired businesses, including through strategic initiatives and new product launches. BD disclosed that the combination generated a $4 billion cash distribution, which was used for share repurchases and debt repayment. Waters continued to identify integration execution and acquisition-related accounting charges as material financial factors.

Key facts

• Cetera Investment Advisers increased its stake in Waters Corporation by 121.0%, owning 13,097 shares after buying an additional 7,172 shares source
• The revenue increase was primarily driven by the acquisition of Biosciences and Diagnostic Solutions businesses source